Related Experiment Video
Updated: May 20, 2026

09:45
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
Lung cancer: microRNA and target database.
Challa Kiran1, Ponnala Deepika
1Centre for Cellular and Molecular Biology, India. challa.kiranbio7@gmail.com
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|July 21, 2012
Summary
This review compiles a database of human microRNAs (miRNAs) and their target genes implicated in lung cancer. These findings highlight miRNAs as potential diagnostic markers and therapeutic targets for lung cancer.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- MicroRNAs (miRNAs) are non-coding RNAs regulating gene expression.
- miRNAs play critical roles in cellular processes including cell growth, differentiation, and apoptosis.
- Dysregulation of miRNAs is implicated in tumorigenesis, particularly in lung cancer.
Purpose of the Study:
- To compile a comprehensive database of human miRNAs involved in lung cancer.
- To identify target genes and associated pathways for these miRNAs.
- To provide miRNA sequences and chromosomal locations.
Main Methods:
- Literature review and data compilation from multiple databases (microCosm, PhenomiR, mir2Disease).
- Identification of miRNA sequences and chromosomal locations.
- Analysis of target gene information and associated biological pathways (e.g., cell cycle, apoptosis, angiogenesis).
Main Results:
- A curated database of human miRNAs associated with lung cancer was established.
- Target genes and their involvement in key cancer-related pathways were detailed.
- Sequence and chromosomal location data for numerous miRNAs were provided.
Conclusions:
- miRNAs are significantly involved in lung cancer development.
- The compiled database serves as a valuable resource for lung cancer research.
- miRNAs show promise as diagnostic biomarkers and therapeutic targets for lung cancer.
Related Concept Videos
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...

